Neoadjuvant tamoxifen for operable breast cancer: A need for phase III studies?

Cancer Detection and Prevention

Volumn 24, Issue 5, 2000, Pages 445-451

  Pujol, P ^a   Daures, J P ^a   Rouanet, P ^a   Hermand, J ^a   Domergue, J ^a   Grenier, J ^a   Maudelonde, T ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

Breast cancer; Estrogen receptor; Neoadjuvant therapy; Tamoxifen

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CMF REGIMEN; CYCLOPHOSPHAMIDE; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADJUVANT THERAPY; ARTICLE; BREAST TUMOR; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; PATHOLOGY; PHASE 3 CLINICAL TRIAL; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CLINICAL TRIALS, PHASE III; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; METHOTREXATE; MIDDLE AGED; NEOADJUVANT THERAPY; PILOT PROJECTS; RANDOMIZED CONTROLLED TRIALS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL ANALYSIS; TAMOXIFEN;

EID: 0033675711     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Tamoxifen for early breast cancer: An overview of the randomised trials
2. Should tamoxifen be a primary treatment choice for elderly breast cancer patients with locoregional disease?
3. Prospective randomized trial of tamoxifen versus surgery in elderly patients with breast cancer
4. Primary chemotherapy in surgically resectable breast cancer
5. Neoadjuvant chemotherapy in operable breast cancer
6. The effects of estrogens and anti-estrogens on hormone responsive human breast cancer in long-term tissue culture
7. Hormone receptors: Their role in predicting prognosis and response to endocrine therapy
8. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines
9. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause
10. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen
11. Multiple estrogen receptor assays in human breast cancer
12. Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to estrogen and progesterone receptor status
13. The effect of endocrine therapy on the levels of estrogen and progesterone receptor and transforming growth factor-β1 in metastatic human breast cancer: An immunohistochemical study
14. In vivo stimulation by tamoxifen of cathepsin D RNA level in breast cancer tumor
15. Tamoxifen treatment increases the concentration of 52 K cathepsin D and its precursor in breast cancer tissue
16. Comparative binding of estrogens and its relation to estrogenic potency
17. Effects of tamoxifen on estrogen and progesterone receptor in human breast cancer
18. Effects of short-term antiestrogen treatment of primary breast cancer on estrogen receptor mRNA and protein expression and on estrogen-regulated genes
19. Pure anti-estrogens in breast cancer: Experimental and clinical observations
20. Time at surgery for breast cancer during the menstrual cycle phase and menopause affects pS2 but not cathepsin D levels
21. Effect of short-term prze-operative tamoxifen on the cytological grade of breast cancer
22. Effect of menstrual phase on surgical treatment of breast cancer
23. Effect of menstrual phase on surgical treatment of breast cancer